Antioxidant effects and mechanism of silymarin in oxidative stress induced cardiovascular diseases
The DOI matches its Crossref record; 170 of the 170 references it cites were found in a registry or an index.
Abstract
Cardiovascular diseases (CVDs) are considered as the major reason for mortality and morbidity worldwide. Substantial evidence suggests that increased oxidative stress plays a significant role in the pathogenesis of CVDs, including atherosclerosis, hypertension, vascular endothelial dysfunction and ischemic heart disease. Cellular oxidative stress results in the release of toxic free radicals by endothelial cells and vascular smooth muscle cells that interact with cell components such as protein, DNA or lipid resulting in cardiovascular pathology. Silymarin has antioxidant activities against CVDs and offers protection against oxidative stress-induced hypertension, atherosclerosis and cardiac toxicity. We present a comprehensive review regarding the oxidative stress and protective effects of silymarin in CVDs management. We also aim to provide mechanistic insight of the mechanisms of silymarin action in oxidative stress-induced CVDs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Retraction Notice: Phytochemicals from Plants to Combat Cardiovascular Disease
Vasanthi, ShriShriMal, N., & Das, D. K. (2012) · Current Medicinal Chemistry · doi:10.2174/092986712800229078 · Cited by 178
RetractedKadir, F. A., Kassim, N. M., Abdulla, M. A., Kamalıdehghan, B., Ahmadipour, F., & Yehye, W. A. (2014) · The Scientific World JOURNAL · doi:10.1155/2014/301879 · Cited by 33
RetractedNitric oxide: physiology, pathophysiology, and pharmacology.
Moncada, S., Palmer, R. M., & Higgs, E. A. (1991) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06663-3 · Cited by 15,525
Heart Disease and Stroke Statistics—2017 Update: A Report From the American Heart Association
Benjamin, E. J., Blaha, M. J., Chiuve, S. E., Cushman, M., Das, S. R., Deo, R., de Ferranti, S. D., Floyd, J., Fornage, M., Gillespie, C., et al. (2017) · Circulation · doi:10.1161/cir.0000000000000485 · Cited by 12,591
Free Radicals in the Physiological Control of Cell Function
Dröge, W. (2002) · Physiological Reviews · doi:10.1152/physrev.00018.2001 · Cited by 9,855
How mitochondria produce reactive oxygen species
Murphy, M. P. (2009) · Biochemical Journal · doi:10.1042/bj20081386 · Cited by 8,207
General Cardiovascular Risk Profile for Use in Primary Care: The Framingham Heart Study
D’Agostino, R. B., Vasan, R. S., Pencina, M. J., Wolf, P. A., Cobain, M., Massaro, J. M., & Kannel, W. B. (2008) · Circulation · doi:10.1161/circulationaha.107.699579 · Cited by 7,491
The NOX Family of ROS-Generating NADPH Oxidases: Physiology and Pathophysiology
Bedard, K., & Krause, K.-H. (2007) · Physiological Reviews · doi:10.1152/physrev.00044.2005 · Cited by 6,989
Free radicals, antioxidants and functional foods: impact on human health
Lobo, V, Patil, A., Phatak, A., & Chandra, N. (2010) · Pharmacognosy Reviews · doi:10.4103/0973-7847.70902 · Cited by 5,435
Mitochondrial formation of reactive oxygen species
Turrens, J. F. (2003) · The Journal of Physiology · doi:10.1113/jphysiol.2003.049478 · Cited by 5,084
Oxidative Stress and Antioxidant Defense
Birben, E., Sahiner, U. M., Sackesen, C., Erzurum, S., & Kalayci, O. (2012) · World Allergy Organization Journal · doi:10.1097/wox.0b013e3182439613 · Cited by 4,935
Oxidative stress: oxidants and antioxidants
Sies, H. (1997) · Experimental Physiology · doi:10.1113/expphysiol.1997.sp004024 · Cited by 4,566
Hubert, H. B., Feinleib, M., McNamara, P. M., & Castelli, W. P. (1983) · Circulation · doi:10.1161/01.cir.67.5.968 · Cited by 4,241
ROS as signalling molecules: Mechanisms that generate specificity in ROS homeostasis
D'Autréaux, B., & Toledano, M. B. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2256 · Cited by 3,642
Selected major risk factors and global and regional burden of disease
Ezzati, M., Lopez, A. D., Rodgers, A., Vander Hoorn, S., & Murray, C. J. (2002) · The Lancet · doi:10.1016/s0140-6736(02)11403-6 · Cited by 3,594
Physiological Roles of Mitochondrial Reactive Oxygen Species
Sena, L. A., & Chandel, N. S. (2012) · Molecular Cell · doi:10.1016/j.molcel.2012.09.025 · Cited by 2,632
Role of Oxidative Modifications in Atherosclerosis
Stocker, R., & Keaney, J. F. (2004) · Physiological Reviews · doi:10.1152/physrev.00047.2003 · Cited by 2,624
The pathophysiology of cigarette smoking and cardiovascular disease
Ambrose, J. A., & Barua, R. S. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2003.12.047 · Cited by 2,394
Antioxidant enzymes and human diseases
MatÉs, J. M., Pérez-Gómez, C., & De Castro, I. N. (1999) · Clinical Biochemistry · doi:10.1016/s0009-9120(99)00075-2 · Cited by 2,099
Heitzer, T., Schlinzig, T., Krohn, K., Meinertz, T., & Münzel, T. (2001) · Circulation · doi:10.1161/hc4601.099485 · Cited by 1,961
Endothelial Nitric Oxide Synthase in Vascular Disease: From Marvel to Menace
Förstermann, U., & Münzel, T. (2006) · Circulation · doi:10.1161/circulationaha.105.602532 · Cited by 1,957
Antioxidants in health and disease
Young, I. S., & Woodside, J. V. (2001) · Journal of Clinical Pathology · doi:10.1136/jcp.54.3.176 · Cited by 1,949
Free radicals, oxidative stress, and antioxidants in human health and disease
Aruoma, O. I. (1998) · Journal of the American Oil Chemists' Society · doi:10.1007/s11746-998-0032-9 · Cited by 1,682
Landmesser, U., Dikalov, S., Price, S. R., McCann, L., Fukai, T., Holland, S. M., Mitch, W. E., & Harrison, D. G. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200314172 · Cited by 1,660
Landmesser, U., Dikalov, S., Price, S. R., McCann, L. A., Fukai, T., Holland, S. M., Mitch, W. E., & Harrison, D. G. (2003) · Journal of Clinical Investigation · doi:10.1172/jci14172 · Cited by 1,655
Free radicals, reactive oxygen species, oxidative stress and its classification
Lushchak, V. I. (2014) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2014.10.016 · Cited by 1,649
Oxidative Stress and Vascular Disease
Madamanchi, N. R., Vendrov, A., & Runge, M. S. (2005) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000150649.39934.13 · Cited by 1,618
Production of Reactive Oxygen Species by Mitochondria
Chen, Q., Vazquez, E. J., Moghaddas, S., Hoppel, C. L., & Lesnefsky, E. J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m304854200 · Cited by 1,616
Oxygen, oxidative stress, hypoxia, and heart failure
Giordano, F. J. (2005) · Journal of Clinical Investigation · doi:10.1172/jci200524408 · Cited by 1,496
Role of oxidative stress in cardiovascular diseases
Dhalla, N. S., Temsah, R. M., & Netticadan, T. (2000) · Journal of Hypertension · doi:10.1097/00004872-200018060-00002 · Cited by 1,467
Ishii, T., Itoh, K., Takahashi, S., Sato, H., Yanagawa, T., Katoh, Y., Bannai, S., & Yamamoto, M. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.21.16023 · Cited by 1,460
The evolution of free radicals and oxidative stress
McCord, J. M. (2000) · The American Journal of Medicine · doi:10.1016/s0002-9343(00)00412-5 · Cited by 1,407
Antioxidants and Atherosclerotic Heart Disease
Diaz, M. N., Frei, B., Vita, J. A., & Keaney, J. F. (1997) · New England Journal of Medicine · doi:10.1056/nejm199708073370607 · Cited by 1,353
HERRERO, M., CIFUENTES, A., & IBANEZ, E. (2006) · Food Chemistry · doi:10.1016/j.foodchem.2005.05.058 · Cited by 1,212
Reactive oxygen species: from health to disease
Brieger, K., Schiavone, S., Miller Jr., F. J., & Krause, K.-H. (2012) · Swiss Medical Weekly · doi:10.4414/smw.2012.13659 · Cited by 1,133
"Portal" adipose tissue as a generator of risk factors for cardiovascular disease and diabetes.
Björntorp, P. (1990) · Arteriosclerosis: An Official Journal of the American Heart Association, Inc. · doi:10.1161/01.atv.10.4.493 · Cited by 1,127
Anderson, T. J., Meredith, I. T., Yeung, A. C., Frei, B., Selwyn, A. P., & Ganz, P. (1995) · New England Journal of Medicine · doi:10.1056/nejm199502233320802 · Cited by 1,109
Hein, S., Arnon, E., Kostin, S., Schönburg, M., Elsässer, A., Polyakova, V., Bauer, E. P., Klövekorn, W.-P., & Schaper, J. (2003) · Circulation · doi:10.1161/01.cir.0000051865.66123.b7 · Cited by 1,102
Human Physiology : From Cells to Systems
Sherwood, L. (1989) · Cited by 956
Peroxynitrite, a Stealthy Biological Oxidant
Radi, R. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.r113.472936 · Cited by 888
Touyz, R. M. (2004) · Hypertension · doi:10.1161/01.hyp.0000138070.47616.9d · Cited by 866
Measurement and Clinical Significance of Biomarkers of Oxidative Stress in Humans
Marrocco, I., Altieri, F., & Peluso, I. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/6501046 · Cited by 855
Superoxide Production and Expression of Nox Family Proteins in Human Atherosclerosis
Sorescu, D., Weiss, D., Lassègue, B., Clempus, R. E., Szöcs, K., Sorescu, G. P., Valppu, L., Quinn, M. T., Lambeth, J. D., Vega, J. D., et al. (2002) · Circulation · doi:10.1161/01.cir.0000012917.74432.66 · Cited by 847
Biological markers of oxidative stress: Applications to cardiovascular research and practice
Ho, E., Karimi Galougahi, K., Liu, C.-C., Bhindi, R., & Figtree, G. A. (2013) · Redox Biology · doi:10.1016/j.redox.2013.07.006 · Cited by 811
NADPH oxidase 4 (Nox4) is a major source of oxidative stress in the failing heart
Kuroda, J., Ago, T., Matsushima, S., Zhai, P., Schneider, M. D., & Sadoshima, J. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1002178107 · Cited by 772
Reactive oxygen species in cardiovascular disease
Sugamura, K., & Keaney (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.05.004 · Cited by 769
Silymarin as a Natural Antioxidant: An Overview of the Current Evidence and Perspectives
Surai, P. (2015) · Antioxidants · doi:10.3390/antiox4010204 · Cited by 738
Cardiotoxicity of Chemotherapeutic Agents: Incidence, Treatment and Prevention
Pai, V. B., & Nahata, M. C. (2000) · Drug Safety · doi:10.2165/00002018-200022040-00002 · Cited by 729
Antioxidants and Oxidative Stress in Exercise
Ji, L. L. (1999) · Proceedings of the Society for Experimental Biology and Medicine · doi:10.1046/j.1525-1373.1999.d01-145.x · Cited by 728
New concepts in reactive oxygen species and cardiovascular reperfusion physiology
Becker, L. (2004) · Cardiovascular Research · doi:10.1016/j.cardiores.2003.10.025 · Cited by 704
Reactive nitrogen species in the chemical biology of inflammation
Dedon, P. C., & Tannenbaum, S. R. (2004) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2003.12.017 · Cited by 681
Billings, H. J. (2019) · The Research Repository @ WVU (West Virginia University) · Cited by 662
Nrf2 regulates ROS production by mitochondria and NADPH oxidase
Kovac, S., Angelova, P. R., Holmström, K. M., Zhang, Y., Dinkova-Kostova, A. T., & Abramov, A. Y. (2015) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2014.11.021 · Cited by 604
Milk thistle in liver diseases: past, present, future
Abenavoli, L., Capasso, R., Milic, N., & Capasso, F. (2010) · Phytotherapy Research · doi:10.1002/ptr.3207 · Cited by 599
NADPH Oxidases: Functions and Pathologies in the Vasculature
Lassègue, B., & Griendling, K. K. (2010) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.108.181610 · Cited by 592
Silybin and Silymarin - New and Emerging Applications in Medicine
Gazak, R., Walterova, D., & Kren, V. (2007) · Current Medicinal Chemistry · doi:10.2174/092986707779941159 · Cited by 573
FREE RADICALS, ANTIOXIDANTS, DISEASES AND PHYTOMEDICINES: CURRENT STATUS AND FUTURE PROSPECT
Sen, S., Chakraborty, R., Sridhar, C., Reddy, Y. S., & De, B. (2010) · Cited by 569
Monogenic hypercholesterolemia: new insights in pathogenesis and treatment
Rader, D. J., Cohen, J., & Hobbs, H. H. (2003) · Journal of Clinical Investigation · doi:10.1172/jci18925 · Cited by 560
Drug-induced mitochondrial dysfunction and cardiotoxicity
Varga, Z. V., Ferdinandy, P., Liaudet, L., & Pacher, P. (2015) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00554.2015 · Cited by 531
The E-loop Is Involved in Hydrogen Peroxide Formation by the NADPH Oxidase Nox4
Takac, I., Schröder, K., Zhang, L., Lardy, B., Anilkumar, N., Lambeth, J. D., Shah, A. M., Morel, F., & Brandes, R. P. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.192138 · Cited by 523
Oxidative stress and protein aggregation during biological aging
Squier, T. C. (2001) · Experimental Gerontology · doi:10.1016/s0531-5565(01)00139-5 · Cited by 508
Nox1 Is Involved in Angiotensin II–Mediated Hypertension: A Study in Nox1-Deficient Mice
Matsuno, K., Yamada, H., Iwata, K., Jin, D., Katsuyama, M., Matsuki, M., Takai, S., Yamanishi, K., Miyazaki, M., Matsubara, H., et al. (2005) · Circulation · doi:10.1161/circulationaha.105.573709 · Cited by 470
Angiotensin II, NADPH Oxidase, and Redox Signaling in the Vasculature
Nguyen Dinh Cat, A., Montezano, A. C., Burger, D., & Touyz, R. M. (2013) · Antioxidants & Redox Signaling · doi:10.1089/ars.2012.4641 · Cited by 464
T Regulatory Lymphocytes Prevent Angiotensin II–Induced Hypertension and Vascular Injury
Barhoumi, T., Kasal, D. A., Li, M. W., Shbat, L., Laurant, P., Neves, M. F., Paradis, P., & Schiffrin, E. L. (2011) · Hypertension · doi:10.1161/hypertensionaha.110.162941 · Cited by 459
Oxidative Stress and Hypertension
Harrison, D. G., & Gongora, M. C. (2009) · Medical Clinics of North America · doi:10.1016/j.mcna.2009.02.015 · Cited by 445
Mitochondrial reactive oxygen species-mediated signaling in endothelial cells
Zhang, D. X., & Gutterman, D. D. (2007) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01283.2006 · Cited by 439
Münzel, T., Gori, T., Keaney, J. F., Maack, C., & Daiber, A. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehv305 · Cited by 394
NADPH oxidases and angiotensin II receptor signaling
Garrido, A. M., & Griendling, K. K. (2009) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2008.11.003 · Cited by 386
Fraschini, F., Demartini, G., & Esposti, D. (2002) · Clinical Drug Investigation · doi:10.2165/00044011-200222010-00007 · Cited by 380
"Silymarin", a promising pharmacological agent for treatment of diseases.
Karimi, G., Vahabzadeh, M., Lari, P., Rashedinia, M., & Moshiri, M. (2011) · PubMed Central · Cited by 379
The NOX toolbox: validating the role of NADPH oxidases in physiology and disease
Altenhöfer, S., Kleikers, P. W. M., Radermacher, K. A., Scheurer, P., Rob Hermans, J. J., Schiffers, P., Ho, H., Wingler, K., & Schmidt, H. H. H. W. (2012) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-012-1010-9 · Cited by 371
Cathcart, M. K. (2004) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000097769.47306.12 · Cited by 365
Oxidative Stress as a Mediator of Cardiovascular Disease
Elahi, M. M., Kong, Y. X., & Matata, B. M. (2009) · Oxidative Medicine and Cellular Longevity · doi:10.4161/oxim.2.5.9441 · Cited by 360
Reactive oxygen species signaling in vascular smooth muscle cells
CLEMPUS, R., & GRIENDLING, K. (2006) · Cardiovascular Research · doi:10.1016/j.cardiores.2006.02.033 · Cited by 358
Szabó, C., Cuzzocrea, S., Zingarelli, B., O'Connor, M., & Salzman, A. L. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119585 · Cited by 354
Reactive oxygen species in hypertension*1An update
LASSEGUE, B. (2004) · American Journal of Hypertension · doi:10.1016/j.amjhyper.2004.02.004 · Cited by 342
Oxidative stress and cardiovascular disease: Novel tools give (free) radical insight
Fearon, I. M., & Faux, S. P. (2009) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2009.05.013 · Cited by 328
Expression and Localization of NOX2 and NOX4 in Primary Human Endothelial Cells
Buul, J. D. V., Fernandez-Borja, M., Anthony, E. C., & Hordijk, P. L. (2005) · Antioxidants & Redox Signaling · doi:10.1089/ars.2005.7.308 · Cited by 326
Zhang, S., & Morris, M. E. (2003) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.044412 · Cited by 309
Dietary Antioxidant Compounds and Liver Health
Vitaglione, P., Morisco, F., Caporaso, N., & Fogliano, V. (2004) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408690490911701 · Cited by 305
Global Noncommunicable Diseases — Where Worlds Meet
Narayan, K. M. V., Ali, M. K., & Koplan, J. P. (2010) · New England Journal of Medicine · doi:10.1056/nejmp1002024 · Cited by 304
Ray, K. K., Kastelein, J. J. P., Matthijs Boekholdt, S., Nicholls, S. J., Khaw, K.-T., Ballantyne, C. M., Catapano, A. L., Reiner, E., & Luscher, T. F. (2014) · European Heart Journal · doi:10.1093/eurheartj/ehu107 · Cited by 301
The ABC Clinical Guide to Herbs
Blumenthal, M. (2003) · Cited by 299
Biomarkers of lipid peroxidation in clinical material
Niki, E. (2014) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2013.03.020 · Cited by 297
Are Free Radicals Involved in the Pathobiology of Human Essential Hypertension?
Kumar, K. V., & Das, U. N. (1993) · Free Radical Research Communications · doi:10.3109/10715769309056499 · Cited by 296
Free Radical Scavenging by Natural Polyphenols: Atom versus Electron Transfer
Di Meo, F., Lemaur, V., Cornil, J., Lazzaroni, R., Duroux, J.-L., Olivier, Y., & Trouillas, P. (2013) · The Journal of Physical Chemistry A · doi:10.1021/jp3116319 · Cited by 294
Silymarin suppresses TNF-induced activation of NF-kappa B, c-Jun N-terminal kinase, and apoptosis.
Manna, S. K., Mukhopadhyay, A., Van, N. T., & Aggarwal, B. B. (1999) · PubMed · Cited by 293
Silymarin Suppresses TNF-Induced Activation of NF-κB, c-Jun N-Terminal Kinase, and Apoptosis
Manna, S. K., Mukhopadhyay, A., Van, N. T., & Aggarwal, B. B. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.12.6800 · Cited by 273
Analysis of the active components of silymarin
Kvasnička, F., Bı́ba, B., Ševčı́k, R., Voldřich, M., & Krátká, J. (2003) · Journal of Chromatography A · doi:10.1016/s0021-9673(02)01971-4 · Cited by 262
Role of endoplasmic reticulum stress in drug‐induced toxicity
Foufelle, F., & Fromenty, B. (2016) · Pharmacology Research & Perspectives · doi:10.1002/prp2.211 · Cited by 246
Redox activation of Nrf2 & NF-κB: A double end sword?
Buelna-Chontal, M., & Zazueta, C. (2013) · Cellular Signalling · doi:10.1016/j.cellsig.2013.08.007 · Cited by 239
Montezano, A. C., & Touyz, R. M. (2012) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2012.01.017 · Cited by 231
El-Samaligy, M. S., Afifi, N. N., & Mahmoud, E. A. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.11.006 · Cited by 226
Athyros, V. G., Alexandrides, T. K., Bilianou, H., Cholongitas, E., Doumas, M., Ganotakis, E. S., Goudevenos, J., Elisaf, M. S., Germanidis, G., Giouleme, O., et al. (2017) · Metabolism · doi:10.1016/j.metabol.2017.02.014 · Cited by 219
Arsenic and fluoride: two major ground water pollutants.
Chouhan, S., & Flora, S. J. S. (2010) · PubMed · Cited by 217
Physiological Roles of Xanthine Oxidoreductase
Harrison, R. (2004) · Drug Metabolism Reviews · doi:10.1081/dmr-120037569 · Cited by 215
Role of urate, xanthine oxidase and the effects of allopurinol in vascular oxidative stress
George, J. (2009) · Vascular Health and Risk Management · doi:10.2147/vhrm.s4265 · Cited by 214
Oxidative Stress and Vascular Disease: 2005 Duff Lecture
Heistad, D. D. (2006) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000203525.62147.28 · Cited by 209
Wang, Y., Chun, O., & Song, W. (2013) · Nutrients · doi:10.3390/nu5082969 · Cited by 190
Silymarin increases antioxidant enzymes in alloxan-induced diabetes in rat pancreas
Soto, C., Recoba, R., Barrón, H., Alvarez, C., & Favari, L. (2003) · Comparative Biochemistry and Physiology Part C: Toxicology & Pharmacology · doi:10.1016/s1532-0456(03)00214-x · Cited by 188
Lipid (per) oxidation in mitochondria: an emerging target in the ageing process?
Ademowo, O. S., Dias, H. K. I., Burton, D. G. A., & Griffiths, H. R. (2017) · Biogerontology · doi:10.1007/s10522-017-9710-z · Cited by 184
An Updated Systematic Review of the Pharmacology of Silymarin
Saller, R., Melzer, J., Reichling, J., Brignoli, R., & Meier, R. F. (2007) · Complementary Medicine Research · doi:10.1159/000100581 · Cited by 181
The NADPH oxidase Nox4 has anti-atherosclerotic functions
Schürmann, C., Rezende, F., Kruse, C., Yasar, Y., Löwe, O., Fork, C., van de Sluis, B., Bremer, R., Weissmann, N., Shah, A. M., et al. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehv460 · Cited by 177
Increased Nox2 expression in human cardiomyocytes after acute myocardial infarction
Krijnen, P. A. J., Meischl, C., Hack, C. E., Meijer, C. J. L. M., Visser, C. A., Roos, D., & Niessen, H. W. M. (2003) · Journal of Clinical Pathology · doi:10.1136/jcp.56.3.194 · Cited by 175
Human Physiology From Cells to Systems
Sophie, W. (2016) · Cited by 170
ROS signaling and redox biology in endothelial cells
Panieri, E., & Santoro, M. M. (2015) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-015-1928-9 · Cited by 168
Role of free radical in atherosclerosis, diabetes and dyslipidaemia: larger‐than‐life
Singh, R., Devi, S., & Gollen, R. (2015) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2558 · Cited by 168
Dawson, J., & Walters, M. (2006) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2006.02785.x · Cited by 167
Free Radical Scavenging and Antioxidant Activities of Silymarin Components
Anthony, K., & SALEH, M. A. (2013) · Antioxidants · doi:10.3390/antiox2040398 · Cited by 163
Tamayo, C., & Diamond, S. (2007) · Integrative Cancer Therapies · doi:10.1177/1534735407301942 · Cited by 156
Silymarin prevents adriamycin-induced cardiotoxicity and nephrotoxicity in rats
El‐Shitany, N. A., El-Haggar, S. M., & El-desoky, K. (2008) · Food and Chemical Toxicology · doi:10.1016/j.fct.2008.03.033 · Cited by 156
Antioxidant and Hepatoprotective Effects of Silibinin in a Rat Model of Nonalcoholic Steatohepatitis
Haddad, Y. K., Vallerand, D., Brault, A., & Haddad, P. S. (2009) · Evidence-based Complementary and Alternative Medicine · doi:10.1093/ecam/nep164 · Cited by 155
Pharmacogenetics of Membrane Transporters: An Update on Current Approaches
Sissung, T. M., Baum, C. E., Kirkland, C. T., Gao, R., Gardner, E. R., & Figg, W. D. (2009) · Molecular Biotechnology · doi:10.1007/s12033-009-9220-6 · Cited by 146
Toth, P. P., Patti, A. M., Nikolić, D., Giglio, R. V., Castellino, G., Biancucci, T., Geraci, F., David, S., Montalto, G., Rizvi, A. A., et al. (2016) · Frontiers in Pharmacology · doi:10.3389/fphar.2015.00299 · Cited by 143
Endothelial Function as a Functional Expression of Cardiovascular Risk Factors
Reriani, M., Lerman, L. O., & Lerman, A. (2010) · Biomarkers in Medicine · doi:10.2217/bmm.10.61 · Cited by 138
Inhibition Studies of Bovine Xanthine Oxidase by Luteolin, Silibinin, Quercetin, and Curcumin
Pauff, J. M., & Hille, R. (2009) · Journal of Natural Products · doi:10.1021/np8007123 · Cited by 133
Antioxidant therapy for management of oxidative stress induced hypertension
Ahmad, K. A., Yuan, D. Y., Nawaz, W., Hong, Z., Zhuo, C. X., Talal, B., Taleb, A., Mais, E., & Qi-long, D. (2017) · Free Radical Research · doi:10.1080/10715762.2017.1322205 · Cited by 132
Self-citationCellular and Molecular Mechanisms of Arrhythmia by Oxidative Stress
Sovari, A. A. (2016) · Cardiology Research and Practice · doi:10.1155/2016/9656078 · Cited by 126
Atherosclerosis: from lesion formation to plaque activation and endothelial dysfunction
Keaney, J. F. (2000) · Molecular Aspects of Medicine · doi:10.1016/s0098-2997(00)00005-4 · Cited by 125
Silymarin Inhibits the Development of Diet-Induced Hypercholesterolemia in Rats
Krecman, V., Škottová, N., Walterová, D., Ulrichová, J., & Šimánek, V. (1998) · Planta Medica · doi:10.1055/s-2006-957391 · Cited by 123
Leonarduzzi, G., Gamba, P., Gargiulo, S., Biasi, F., & Poli, G. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.09.031 · Cited by 122
Hou, Y.-C., Liou, K., Chern, C., Wang, Y., Liao, J., Chang, S., Chou, Y.-H., & Shen, Y. (2010) · Phytomedicine · doi:10.1016/j.phymed.2010.03.012 · Cited by 122
Zhong, S., Fan, Y., Yan, Q., Fan, X., Wu, B., Han, Y., Zhang, Y., Chen, Y., Zhang, H., & Niu, J. (2017) · Medicine · doi:10.1097/md.0000000000009061 · Cited by 120
Guzik, T. J., Sadowski, J., Kapelak, B., Jopek, A., Rudzinski, P., Pillai, R., Korbut, R., & Channon, K. M. (2004) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000139011.94634.9d · Cited by 119
Atherothrombosis and Oxidative Stress: Mechanisms and Management in Elderly
Violi, F., Loffredo, L., Carnevale, R., Pignatelli, P., & Pastori, D. (2017) · Antioxidants & Redox Signaling · doi:10.1089/ars.2016.6963 · Cited by 118
Viel, E. C., Benkirane, K., Javeshghani, D., Touyz, R. M., & Schiffrin, E. L. (2008) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00304.2008 · Cited by 116
Pressure-Independent Effects of Angiotensin II on Hypertensive Myocardial Fibrosis
Tokuda, K., Kai, H., Kuwahara, F., Yasukawa, H., Tahara, N., Kudo, H., Takemiya, K., Koga, M., Yamamoto, T., & Imaizumi, T. (2004) · Hypertension · doi:10.1161/01.hyp.0000111831.50834.93 · Cited by 115
Muthumani, M., & Prabu, S. M. (2013) · Cardiovascular Toxicology · doi:10.1007/s12012-013-9227-x · Cited by 114
Effect of silymarin and its polyphenolic fraction on cholesterol absorption in rats
Sobolová, L., Škottová, N., Večeřa, R., & Urbánek, K. (2005) · Pharmacological Research · doi:10.1016/j.phrs.2005.09.004 · Cited by 108
Lee, J. I., Hsu, B. H., Wu, D., & Barrett, J. S. (2006) · Journal of Chromatography A · doi:10.1016/j.chroma.2006.03.053 · Cited by 101
Tetrahydrobiopterin in Nitric Oxide Synthesis: A Novel Biological Role for Pteridines
Gorren, A., & Mayer, B. (2002) · Current Drug Metabolism · doi:10.2174/1389200024605154 · Cited by 99
Dietary Antioxidants in Health and Disease
Morrissey, P. A., & O’Brien, N. M. (1998) · International Dairy Journal · doi:10.1016/s0958-6946(98)00070-3 · Cited by 96
Prevention of diabetes-induced cardiovascular complications upon treatment with antioxidants
Xu, Y., Tappia, P. S., Neki, N. S., & Dhalla, N. S. (2013) · Heart Failure Reviews · doi:10.1007/s10741-013-9379-6 · Cited by 94
NF- B activation is required for adaptive cardiac hypertrophy
Zelarayan, L. C., Renger, A., Noack, C., Zafeiriou, M.-P., Gehrke, C., van der Nagel, R., Dietz, R., Windt, L. J. D., & Bergmann, M. W. (2009) · Cardiovascular Research · doi:10.1093/cvr/cvp237 · Cited by 93
Hypercholesterolemia and Hypertension: Two Sides of the Same Coin
Ivanović, B., & Tadić, M. (2015) · American Journal of Cardiovascular Drugs · doi:10.1007/s40256-015-0128-1 · Cited by 89
Implications of Oxidative Stress and Homocysteine in the Pathophysiology of Essential Hypertension
Rodrigo, R., Passalacqua, W., Araya, J., Orellana, M., & Rivera, G. (2003) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-200310000-00001 · Cited by 85
Anilkumar, N., Jose, G. S., Sawyer, I., Santos, C. X. C., Sand, C., Brewer, A. C., Warren, D., & Shah, A. M. (2013) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.112.300956 · Cited by 84
Turgut, F. H., Bayrak, Ö., Çatal, F., Bayrak, R., Atmaca, A. F., Koç, A., Akbaş, A., Akçay, A., & Ünal, D. (2008) · International Urology and Nephrology · doi:10.1007/s11255-008-9365-4 · Cited by 83
Chlopčíková, Š., Psotová, J., Miketová, P., & Šimánek, V. (2004) · Phytotherapy Research · doi:10.1002/ptr.1415 · Cited by 78
Effect of silibinin on endothelial dysfunction and ADMA levels in obese diabetic mice
Volti, G. L., Salomone, S., Sorrenti, V., Mangiameli, A., Urso, V., Siarkos, I., Galvano, F., & Salomone, F. (2011) · Cardiovascular Diabetology · doi:10.1186/1475-2840-10-62 · Cited by 77
Silymarin and its constituents in cardiac preconditioning
Zholobenko, A. V., & Modrianský, M. (2014) · Fitoterapia · doi:10.1016/j.fitote.2014.05.016 · Cited by 76
Li, X., Yuan, Q., Huang, Y., Zhou, Y., & Liu, Y. (2010) · AAPS PharmSciTech · doi:10.1208/s12249-010-9432-x · Cited by 76
Cristofalo, R., Bannwart-Castro, C. F., Magalhães, C. G., Borges, V. T. M., Peraçoli, J. C., Witkin, S. S., & Peraçoli, M. T. (2013) · Free Radical Research · doi:10.3109/10715762.2013.765951 · Cited by 66
Yu, X., Zhang, D., Jia, L., Qi, J., Song, X., Tan, H., Cui, W., Chen, W., Zhu, G., Qin, D.-N., et al. (2015) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2015.02.023 · Cited by 63
Quesada, I. M., Lucero, A., Amaya, C., Meijles, D. N., Cifuentes, M. E., Pagano, P. J., & Castro, C. (2015) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2015.08.011 · Cited by 54
Protective Effect of Silymarin against Acrolein-Induced Cardiotoxicity in Mice
Taghiabadi, E., Imenshahidi, M., Abnous, K., Mosaffa, F., Sankian, M., Memar, B., & Karimi, G. (2012) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2012/352091 · Cited by 51
Kang, J. S., Park, S., Yang, K., & Kim, H. M. (2003) · FEBS Letters · doi:10.1016/s0014-5793(03)00827-5 · Cited by 50
Anestopoulos, I., Kavo, A. E., Tentes, I. K., Kortsaris, A., Panayiotidis, M. I., Lazou, A., & Pappa, A. (2012) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2012.02.009 · Cited by 50
Gawron-Skarbek, A., Chrzczanowicz, J., Kostka, J., Nowak, D., Drygas, W., Jegier, A., & Kostka, T. (2014) · BioMed Research International · doi:10.1155/2014/216964 · Cited by 49
NADPH Oxidase Deficiency: A Multisystem Approach
Giardino, G., Cicalese, M. P., Delmonte, O. M., Migliavacca, M., Palterer, B., Loffredo, L., Cirillo, E., Gallo, V., Violi, F., & Pignata, C. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/4590127 · Cited by 49
Structure prerequisite for antioxidant activity of silybin in different biochemical systems in vitro
Varga, Z., Seres, I., Nagy, E., Újhelyi, L., Balla, G., Balla, J., & Antus, S. (2005) · Phytomedicine · doi:10.1016/j.phymed.2004.06.019 · Cited by 46
Different effects of hypertension, atherosclerosis and hyperlipidaemia on arterial distensibility
Hoeks, A. P. G., Barenbrock, M., Spieker, C., Kerber, S., Vielhauer, C., Zidek, W., & Rahn, K. H. (1995) · Journal of Hypertension · doi:10.1097/00004872-199512010-00037 · Cited by 43
Protective role of silymarin against manganese‐induced nephrotoxicity and oxidative stress in rat
Chtourou, Y., Garoui, E. M., Boudawara, T. S., & Zeghal, N. (2013) · Environmental Toxicology · doi:10.1002/tox.21845 · Cited by 43
Wang, Y., Hong, Y.-J., & Huang, Z. (2005) · Vascular Pharmacology · doi:10.1016/j.vph.2005.06.002 · Cited by 37
Violi, F., Sanguigni, V., Loffredo, L., Carnevale, R., Buchetti, B., Finocchi, A., Tesauro, M., Rossi, P., & Pignatelli, P. (2006) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000229710.13054.2d · Cited by 36
Atawia, R. T., Mosli, H. H., Tadros, M. G., Khalifa, A. E., Mosli, H. A. M., & Abdel‐Naim, A. B. (2014) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-014-1040-y · Cited by 33
Does NADPH Oxidase Deficiency Cause Artery Dilatation in Humans?
Loffredo, L., Carnevale, R., Sanguigni, V., Plebani, A., Rossi, P., Pignata, C., Mattia, D. D., Finocchi, A., Martire, B., Pietrogrande, M. C., et al. (2012) · Antioxidants and Redox Signaling · doi:10.1089/ars.2012.4987 · Cited by 32
Jin, Y., Zhao, X., Zhang, H., Li, Q., Lu, G., & Zhao, X. (2016) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2016.3370 · Cited by 26
The Effect of Silymarin on Mesenteric Ischemia-Reperfusion Injury
Demir, M., Amanvermez, R., Polat, A. K., Karabıçak, İ., Çınar, H. U., Kesicioğlu, T., & Polat, C. (2013) · Medical Principles and Practice · doi:10.1159/000356860 · Cited by 26
Nebivolol: a Multifaceted Antioxidant and Cardioprotectant in Hypertensive Heart Disease
Khan, M. U., Zhao, W., Zhao, T., Darazi, F. A., Ahokas, R. A., Sun, Y., Bhattacharya, S. K., Gerling, I., & Weber, K. T. (2013) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0b013e3182a0b5ff · Cited by 25
Pathophysiology of Cardiovascular Disease
(2004) · Progress in experimental cardiology · doi:10.1007/978-1-4615-0453-5 · Cited by 25
Effect of silymarin on liver phoshpatidate phosphohydrolase in hyperlipidemic rats
Heidarian, E., & Rafieian‐Kopaei, M. (2012) · Cited by 20
Chen, H., Chen, S.-C., Zhang, T.-H., Tian, H.-C., Guan, Y., & Su, D. (1993) · International Journal of Cardiology · doi:10.1016/0167-5273(93)90148-a · Cited by 19
Milk Thistle: A Future Potential Anti-Osteoporotic and Fracture Healing Agent
Fozi, N. F. M., Mazlan, M., Shuid, A. N., & Mohamed, I. N. (2013) · Current Drug Targets · doi:10.2174/13894501113146660222 · Cited by 15
Silymarin Improves Vascular Function of Aged Ovariectomized Rats
Demirci, B., Dost, T., Gokalp, F., & Birincioğlu, M. (2013) · Phytotherapy Research · doi:10.1002/ptr.5067 · Cited by 15
Jadhav, G. B., & Upasani, C. D. (2011) · Oriental Pharmacy and Experimental Medicine · doi:10.1007/s13596-011-0018-2 · Cited by 14
Biomarkers of Oxidative Stress in Human Hypertension
Tsiropoulou, S., Dulak-Lis, M. G., Montezano, A. C. I., & Touyz, R. M. (2016) · Springer eBooks · doi:10.1007/978-3-319-39599-9_11 · Cited by 12
Srivastava, A. K., Pandey, N. R., & Blanc, A. (2004) · Progress in experimental cardiology · doi:10.1007/978-1-4615-0453-5_30 · Cited by 3
Effect of Antioxidant and Lipid Profile on the Coronary Heart Disease
Ahmad, S., & Al-Sayed, R. S. (2013) · Journal of Al-Nahrain University-Science · doi:10.22401/jnus.16.2.03 · Cited by 2
Cited by
Oxidative Stress in Radiation-Induced Cardiotoxicity
Ping, Z., Peng, Y., Lang, H., Xinyong, C., Zhiyi, Z., Xiaocheng, W., Hong, Z., & Liang, S. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/3579143 · Cited by 187
“Therefore, cellular oxidative stress is the main pathogenic factor of CVD [14].”
BackgroundInfluential
Metadata
- Authors
- Taleb, A., Ahmad, K. A., Ihsan, A. U., Qu, J., Lin, N., Hezam, K., Koju, N., Hui, L., & Qilong, D.
- Venue
- Biomedicine & Pharmacotherapy
- Publisher
- Elsevier BV
- Published
- 2018-06
- Volume
- 102
- Pages
- 689-698
- ISSN
- 0753-3322 (ISSN-L)
- OpenAlex
- W2801642876
- Cited by
- 215
- References
- 170
- FWCI
- 12.01
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.